- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/12 - Radicals substituted by oxygen atoms
Patent holdings for IPC class C07D 235/12
Total number of patents in this class: 191
10-year publication summary
|
14
|
9
|
9
|
20
|
11
|
11
|
9
|
9
|
9
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ecolab USA Inc. | 5361 |
12 |
| Janssen Pharmaceutica N.V. | 3610 |
6 |
| Epizyme, Inc. | 386 |
6 |
| FUJIFILM Corporation | 28841 |
5 |
| Astellas Pharma Inc. | 1122 |
5 |
| Jiangsu Hengrui Medicine Co., Ltd. | 760 |
5 |
| F. Hoffmann-La Roche AG | 7951 |
4 |
| Nippon Shinyaku Co., Ltd. | 324 |
4 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 628 |
4 |
| UCB Biopharma SPRL | 368 |
4 |
| University of Washington through its Center for Commercialization | 509 |
4 |
| Yale University | 2298 |
4 |
| Boehringer Ingelheim International GmbH | 4750 |
3 |
| Allergan, Inc. | 2431 |
3 |
| Takeda Pharmaceutical Company Limited | 2945 |
3 |
| Glenmark Pharmaceuticals S.A. | 120 |
3 |
| UCB Biopharma SRL | 650 |
3 |
| Tmem16a Limited | 14 |
3 |
| Novartis AG | 11254 |
2 |
| Genentech, Inc. | 3878 |
2 |
| Other owners | 106 |